Johnson & Johnson Appeal Of $2 Billion Talc Verdict Rejected By Supreme Court

  • 📰 HuffPostWomen
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 68%

United States Headlines News

United States Latest News,United States Headlines

The company has stopped selling its iconic talc-based Johnson’s Baby Powder in the U.S. and Canada.

in favor of women who claim they developed ovarian cancer from using Johnson & Johnson talc products.

The justices did not comment Tuesday in rejecting Johnson & Johnson’s appeal. The company argued that it was not treated fairly in facing one trial involving 22 cancer sufferers who came from 12 states and different backgrounds., but a state appeals court dropped two women from the suit and reduced the award to $2 billion. The jury found that the company’s talc products contain asbestos and asbestos-laced talc can cause ovarian cancer. The company disputes both points.

Justices Samuel Alito and Brett Kavanaugh took no part in the court’s action. Alito owns $15,000 to $50,000 in Johnson & Johnson stock. Kavanaugh’s father headed the trade association that lobbied against labeling talc a carcinogen and including a warning label on talc products. Ethicists contacted by The Associated Press said they did not think E. Edward Kavanaugh’s role required his son to step aside from the case.

Johnson & Johnson, which is based in New Brunswick, New Jersey, has stopped selling its iconic talc-based Johnson’s Baby Powder in the U.S. and Canada, though it remains on the market elsewhere.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 27. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Supreme Court rejects Johnson & Johnson’s appeal of $2 billion baby-powder verdictThe company argued that it was not treated fairly in facing one trial involving 22 cancer sufferers who came from 12 states and different backgrounds.
Source: MarketWatch - 🏆 3. / 97 Read more »

Supreme Court declines to hear Johnson & Johnson appeal of talcum powder caseThe Supreme Court has declined to hear an appeal by Johnson & Johnson that claimed they did not receive a fair trial during a lawsuit from multiple women who claimed a link between their talcum powder products and cancer. NBC's Pete Williams has details.
Source: MSNBC - 🏆 469. / 51 Read more »

U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgmentThe U.S. Supreme Court on Tuesday declined to hear Johnson & Johnson's (JNJ.N) bid to overturn a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in the company's baby powder and other talc products. annaliesalin Good
Source: Reuters - 🏆 2. / 97 Read more »

Supreme Court won't hear Johnson & Johnson's appeal of $2 billion talcum powder verdictThe company argued that it didn't get a fair trial when a jury awarded nearly $5 billion to 22 women, damages that were later reduced by more than half.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

J&J loses Supreme Court bid to appeal $2.1 billion baby powder judgmentBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know. It’s bunk from what I can see. 20 women wildly different symptoms/effects. No clear pattern relating to cause. Coverup in the 70’s of asbestos being mined close to talcum. Appears using that deception as case. horrible Meanwhile come get your Johnson & Johnson Covid Vaccine. Johnson & Johnson is a trustworthy company and please disregard their lawsuits on opioids and baby powder.
Source: BusinessInsider - 🏆 729. / 51 Read more »

Supreme Court rejects Johnson & Johnson’s appeal of $2 billion baby-powder verdictThe company argued that it was not treated fairly in facing one trial involving 22 cancer sufferers who came from 12 states and different backgrounds.
Source: MarketWatch - 🏆 3. / 97 Read more »